Eclipse Ingredients
Food Biotechnology · Brewing & Beer
Overview
Eclipse uses precision fermentation to produce human lactoferrin and next-generation bioactive ingredients — sustainable, scalable, and bioidentical.
Funding and backers
Backers
2
Plug and Play, AgFunder
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
Registers and programsofficial lists and records that name the company
| Legal entity | Policy Eclipse Ingredients Pty Ltd | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

New Path Bio - Pioneering precision fermentation to produce proteins for nutrition and health, independent of animals, land, water or…

We are a deep tech company leading in animal-free fats and precision fermentation.

Explore the infinite possibilities of Precision Fermentation with Galaxy Biosolutions.

DMC Biotechnologies is a pioneering U.S. biomanufacturer transforming chemical production with precision fermentation. We create…

Future Cow is Brazil’s first foodtech startup developing innovative technology that produces real milk, without cows, using precision…

Discover Verley's innovative precision fermentation technology for sustainable, nutritious, and delicious dairy proteins. Join us in…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors

AgFunderVia a fund

Plug and PlayVia a fund
2741 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Eclipse Ingredients scales human lactoferrin platform: 'We're executing at a speed that is unheard of in this space'
"We've got two platform technologies and we're executing at a speed that is unheard of in this space," says CEO Siobhan Coster.
Read more
Report






